Initializing potency table...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(±)-adrenaline | 3139 | 3H-DHA | 60 | Human | Binding | pKi | = | 10000.00 | 5.00 | -1995 | 14 | - | PDSP KiDatabase | 183.1 | 3 | 4 | 4 | 0.35 | CNCC(O)c1ccc(O)c(O)c1 | - | |
(+)-adrenaline | 290 | None | 26 | Dog | Binding | Ki | = | 3700.00 | 5.43 | -3 | 5 | Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@@H](O)c1ccc(O)c(O)c1 | https://dx.doi.org/10.1021/jm990599h | |
(+)-sulpiride | 3703 | 3H-DHA | 66 | Rat | Binding | pKi | = | 10000.00 | 5.00 | -549 | 23 | - | PDSP KiDatabase | 341.1 | 6 | 2 | 5 | 0.56 | CCN1CCC[C@@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC | - | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | pKi | = | - | 6.10 | -89 | 35 | Unclassified | Guide to Pharmacology | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://pubmed.ncbi.nlm.nih.gov/2849109 | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | pKi | = | - | 6.10 | -89 | 35 | Unclassified | Guide to Pharmacology | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://pubmed.ncbi.nlm.nih.gov/9295336 | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | pKi | = | - | 6.10 | -89 | 35 | Unclassified | Guide to Pharmacology | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://pubmed.ncbi.nlm.nih.gov/14730417 | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | pKi | = | - | 6.10 | -89 | 35 | Unclassified | Guide to Pharmacology | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://pubmed.ncbi.nlm.nih.gov/20590599 | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | Kd | = | 630.00 | 6.20 | -89 | 35 | Binding affinity to human adrenergic beta2 receptor | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://dx.doi.org/10.1016/j.ejmech.2008.12.016 | |
(-)-adrenaline | 291 | 3H-DHA | 40 | Human | Binding | pKi | = | 1100.00 | 5.96 | -89 | 35 | - | PDSP KiDatabase | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | 125I-CYP | 40 | Human | Binding | pKi | = | 735.00 | 6.13 | -89 | 35 | - | PDSP KiDatabase | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | pKd | = | 6.20 | 8.21 | -89 | 35 | Binding affinity to human adrenergic beta2 receptor | Drug Central | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | IC50 | = | 284.00 | 6.55 | -89 | 35 | DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | Ki | = | 196.00 | 6.71 | -89 | 35 | DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | Kd | = | 630.96 | 6.20 | -89 | 35 | Binding affinity to beta-2 adrenergic receptor (unknown origin) at 1 to 10000 nM | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://dx.doi.org/10.1016/j.bmcl.2013.07.052 | |
(-)-adrenaline | 291 | None | 40 | Human | Binding | Ki | = | 360.00 | 6.44 | -89 | 35 | Displacement of [3H]CGP12177 from human beta2 receptor expressed in CHO cells | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://dx.doi.org/10.1016/j.bmc.2016.04.028 | |
(-)-adrenaline | 291 | 125I-ICYP | 40 | Human | Binding | pKi | = | 3467.36 | 5.46 | -89 | 35 | - | PDSP KiDatabase | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | 3H-CGP-12177 | 40 | Human | Binding | pKi | = | 1995.26 | 5.70 | -89 | 35 | - | PDSP KiDatabase | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | None | 40 | Rat | Binding | Ki | = | 720.00 | 6.14 | -12 | 35 | Binding affinity against adrenergic beta 2 receptor versus 1 nM [3H]dihydroalprenolol in rat cerebral cerebellar membranes | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://dx.doi.org/10.1021/jm00076a024 | |
(-)-adrenaline | 291 | None | 40 | Rat | Binding | pKi | = | 6.14 | 8.21 | -12 | 35 | Binding affinity against adrenergic beta 2 receptor versus 1 nM [3H]dihydroalprenolol in rat cerebral cerebellar membranes | Drug Central | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | - | |
(-)-adrenaline | 291 | None | 40 | Dog | Binding | Ki | = | 660.00 | 6.18 | -30 | 35 | Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes | ChEMBL | 183.1 | 3 | 4 | 4 | 0.35 | CNC[C@H](O)c1ccc(O)c(O)c1 | https://dx.doi.org/10.1021/jm990599h |
Showing 1 to 20 of 2,550 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name |
GPCRdb ID |
Reference ligand |
Vendors | Species | Assay Type |
Activity Type |
Activity Relation |
Activity Value |
p-value (-log) |
Fold selectivity |
Tested GPCRs |
Assay Description |
Source | Mol weight |
Rot Bonds |
H don | H acc | LogP | Smiles | DOI | |